Dalriada Drug Discovery and Topos Bio collaborate to accelerate drug discovery for intrinsically disordered proteins using AI, mass spectrometry and proteomics to improve experimental validation and therapeutic development.
Dalriada Drug Discovery | 18/03/2026 | By News Bureau | 142
Concept Life Sciences has appointed Dr Adam Davenport as Chief Scientific Officer (CSO), who brings over 25 years of expertise in life sciences and partnership management to advance the company’s leadership in integrated drug discovery.
Dalriada Drug Discovery | 20/01/2026 | By News Bureau | 215
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy